首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1348360篇
  免费   92424篇
  国内免费   4013篇
耳鼻咽喉   19195篇
儿科学   41430篇
妇产科学   36566篇
基础医学   191969篇
口腔科学   38095篇
临床医学   118511篇
内科学   259130篇
皮肤病学   30636篇
神经病学   101875篇
特种医学   52189篇
外国民族医学   283篇
外科学   205204篇
综合类   30140篇
现状与发展   2篇
一般理论   326篇
预防医学   88567篇
眼科学   32483篇
药学   108478篇
  9篇
中国医学   4553篇
肿瘤学   85156篇
  2021年   10198篇
  2019年   10441篇
  2018年   15280篇
  2017年   11873篇
  2016年   13166篇
  2015年   14746篇
  2014年   20201篇
  2013年   28624篇
  2012年   39349篇
  2011年   41258篇
  2010年   24398篇
  2009年   22821篇
  2008年   37918篇
  2007年   40707篇
  2006年   41024篇
  2005年   38689篇
  2004年   36891篇
  2003年   35325篇
  2002年   34008篇
  2001年   77492篇
  2000年   79426篇
  1999年   65900篇
  1998年   16378篇
  1997年   14171篇
  1996年   13725篇
  1995年   12836篇
  1994年   11559篇
  1993年   10904篇
  1992年   48217篇
  1991年   45853篇
  1990年   44880篇
  1989年   43202篇
  1988年   39135篇
  1987年   37942篇
  1986年   35643篇
  1985年   33351篇
  1984年   23900篇
  1983年   19980篇
  1982年   10880篇
  1979年   20956篇
  1978年   13877篇
  1977年   12441篇
  1976年   10566篇
  1975年   12088篇
  1974年   14011篇
  1973年   13515篇
  1972年   12891篇
  1971年   12221篇
  1970年   11156篇
  1969年   10813篇
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.

Physical activity brings significant health benefits to middle-aged adults, although the research to date has been focused on late adulthood. This study aims to examine how ageing affects the self-reported and accelerometer-derived measures of physical activity levels in middle-aged adults. We employed the data recorded in the UK Biobank and analysed the physical activity levels of 2,998 participants (1381 men and 1617 women), based on self-completion questionnaire and accelerometry measurement of physical activity. We also assessed the musculoskeletal health of the participants using the dual-energy X-ray absorptiometry (DXA) measurements provided by the UK Biobank. Participants were categorised into three groups according to their age: group I younger middle-aged (40 to 49 years), group II older middle-aged (50 to 59 years), and group III oldest middle-aged (60 to 69 years). Self-reported physical activity level increased with age and was the highest in group III, followed by group II and I (P?<?0.05). On the contrary, physical activity measured by accelerometry decreased significantly with age from group I to III (P?<?0.05), and the same pertained to the measurements of musculoskeletal health (P?<?0.05). It was also shown that middle-aged adults mostly engaged in low and moderate intensity activities. The opposing trends of the self-reported and measured physical activity levels may suggest that middle-aged adults over-report their activity level as they age. They should be aware of the difference between their perceived and actual physical activity levels, and objective measures would be useful to prevent the decline in musculoskeletal health.

  相似文献   
5.
6.
7.
8.
9.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号